SHARE
Cardiac Rhythm Management Devices Market

Cardiac Rhythm Management Devices - Global Market Outlook (2018-2027)

4.2 (52 reviews)
Published: November 2019 ID: SMRC18670
4.2 (52 reviews)
Published: November 2019 ID: SMRC18670

This report covers the impact of COVID-19 on this global market

According to Stratistics MRC, the Global Cardiac Rhythm Management Devices Market is accounted for $20.32 billion in 2018 and is expected to reach $42.78 billion by 2027 growing at a CAGR of 8.6% during the forecast period. Increasing awareness regarding cardiac disorders, rising demand for implantable cardioverter-defibrillator devices in developing economies and growing geriatric population base coupled with the rising prevalence of obesity are some of the factors fuelling the market growth. However, High cost of devices and Complications of CRT in children is restricting the market growth.

Cardiac rhythm management is a treatment of arrhythmias (heart rhythm disorders) or atrial fibrillation (AF). Arrhythmia causes palpitations and dizzy spells to sudden cardiac arrest. Cardiac rhythm management devices include pacemakers, cardiac resynchronization therapy devices, and implantable cardiac defibrillators.

Based on the product, the cardiac resynchronization therapy (CRT) segment is anticipated to register lucrative growth over the forecast period. The growth of CRT devices is majorly due to the rising prevalence of heart failure witnessed across the globe. Moreover, Growing number of geriatric population across the globe along with the rising incidence of atrial fibrillation, arrhythmias, congenital heart diseases are some other factors that have augmented the need and demand for resynchronization therapy devices products.

By Geography, North America is expected to have a significant market growth during the forecast period, owing to increasing incidence rate of cardiovascular diseases across various countries in the region, increasing elderly population, ready acceptance of technological advanced products (long battery life, biocompatible materials or miniaturization, & leadless) and increasing regulatory approvals. 

Some of the key players profiled in the Cardiac Rhythm Management Devices market include Abiomed, Inc., Defibtech, LLC., Boston Scientific Corporation, SCHILLER AG, Stryker, Koninklijke Philips N.V., Medtronic plc, General Electric (GE) Company, LivaNova PLC, Cardiac Science Corporation, Hill-Rom Holdings, Inc., Biotronik SE & Co. KG, Berlin Heart GmbH, Abbott Laboratories, St. Jude Medical, and Altera.

Products Covered:
• Defibrillator
• Cardiac Resynchronization Therapy (CRT)
• Pacemakers
• Accessories
• Other Products

Applications Covered:
• Bradycardia
• Heart Failure
• Tachycardia
• Other Applications

End Users Covered:
• Hospitals & Clinics
• Home Care Settings
• Ambulatory Surgery Centers
• Cardiac Centers
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan        
o China        
o India        
o Australia  
o New Zealand
o South Korea
o Rest of Asia Pacific    
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa 
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings: 
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials